Keith L Brownlie is Director of Vyant Bio, Inc.. Currently has a direct ownership of 5,000 shares of VYNT, which is worth approximately $0. The most recent transaction as insider was on May 22, 2014, when has been sold 5,000 shares (Common Stock, par value $0.0001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5K
0% 3M change
0% 12M change
Total Value Held $0

Keith L Brownlie Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 22 2014
BUY
Grant, award, or other acquisition
-
5,000 Added 50.0%
5,000 Common Stock, par valu...

Also insider at

CLDX
Celldex Therapeutics, Inc. Healthcare
KLB

Keith L Brownlie

Director
Rutherford, NJ

Track Institutional and Insider Activities on VYNT

Follow Vyant Bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VYNT shares.

Notify only if

Insider Trading

Get notified when an Vyant Bio, Inc. insider buys or sells VYNT shares.

Notify only if

News

Receive news related to Vyant Bio, Inc.

Track Activities on VYNT